Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2020-11-13 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
109年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning investments in mainland China by the company 生達. It includes specific financial data such as capital amounts, investment gains/losses, and regulatory investment limits. The document is relatively short (1412 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an annual or quarterly report, audit report, or earnings release. Instead, it fits the profile of a Regulatory Filing (RNS) as it is a regulatory disclosure of investment information required by authorities, without being a full financial report or announcement of a report publication.
2020-11-13 Chinese
109年第3季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data related to investments in overseas subsidiaries, including investment amounts, holding percentages, and recognized investment gains or losses for a specific period (109年3季, which corresponds to the third quarter of the 109th year in the Taiwanese calendar). The presence of substantive financial data and analysis for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document is 897 characters long, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is an announcement of a report or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-11-13 Chinese
109年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by insiders, including directors, supervisors, and senior management, showing their stock ownership, changes in holdings, and related notes. It is a typical insider shareholding report, listing personal share transactions or holdings by company directors and executives. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report publication announcement or a certification. It fits the definition of Director's Dealing (DIRS) as it reports personal share transactions by company directors and executives.
2020-11-09 Chinese
109年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed disclosure of shareholdings by insiders and related parties of the company 生達化學製藥股份有限公司. It lists the number of shares held by directors, supervisors, and senior management, including pledged shares and shares held by spouses or minors. The document does not contain financial statements, earnings data, or management discussion. It is a report on insider shareholdings and their changes, which fits the definition of Director's Dealing (DIRS) filings, as it reports personal share transactions or holdings by company directors and executives. The document length is 2389 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is DIRS with high confidence.
2020-11-09 Chinese
109年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to the company's and its subsidiaries' loan balances and endorsement guarantees for a specific month (October 2020). It contains tabulated financial data but is very short (634 characters) and does not present a full financial report or detailed analysis. It appears to be a regulatory disclosure of financial status rather than a full report like an Annual Report or Interim Report. There is no indication of management discussion, audit information, or earnings highlights. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-11-09 Chinese
109年10月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, with data for October of the 109th year of the Republic of China calendar (equivalent to 2020). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (771 characters) and contains no detailed financial statements or management discussion. It appears to be a brief financial summary or factsheet rather than a full report or announcement. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the concise nature and content, the best fit is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2020-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.